$246 Million is the total value of Iguana Healthcare Management, LLC's 82 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PFE | PFIZER INC | $7,042,000 | +18.8% | 200,000 | 0.0% | 2.86% | +31.9% | |
NUVA | NUVASIVE INC | $5,972,000 | +22.8% | 100,000 | 0.0% | 2.43% | +36.2% | |
AMGN | AMGEN INC | $5,325,000 | +1.5% | 35,000 | 0.0% | 2.17% | +12.6% | |
MDRX | ALLSCRIPTS HEALTHCARE SOLUTN | $3,175,000 | -3.9% | 250,000 | 0.0% | 1.29% | +6.8% | |
HWAY | HEALTHWAYS INC | $2,599,000 | +14.5% | 225,000 | 0.0% | 1.06% | +27.0% | |
KITE | KITE PHARMA INC | $2,500,000 | +8.9% | 50,000 | 0.0% | 1.02% | +20.9% | |
SPNC | SPECTRANETICS CORP | $2,058,000 | +28.9% | 110,000 | 0.0% | 0.84% | +43.1% | |
AGTC | APPLIED GENETIC TECHNOL CORP | $1,413,000 | +1.1% | 100,000 | 0.0% | 0.58% | +12.3% | |
SCYX | SCYNEXIS INC | $271,000 | -46.2% | 125,000 | 0.0% | 0.11% | -40.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-11-04
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOGEN INC | 17 | Q1 2018 | 7.5% |
ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
CELGENE CORP | 15 | Q4 2017 | 7.9% |
AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
DERMIRA INC | 14 | Q1 2018 | 2.7% |
AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2018-05-15 |
13F-HR | 2018-02-14 |
13F-HR/A | 2017-11-16 |
13F-HR | 2017-11-14 |
13F-HR | 2017-08-14 |
13F-HR | 2017-05-15 |
13F-HR | 2017-02-14 |
13F-HR/A | 2016-11-17 |
13F-HR | 2016-11-14 |
13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.